Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

詳細情報 詳細情報について

• CRID

  1362544420181678720

• DOI

  10.1093/eurheartj/ehu085

• ISSN

  15229645

  0195668X

• Web Site

  http://academic.oup.com/eurheartj/article-pdf/35/33/2249/17354574/ehu085.pdf

• データソース種別

  • Crossref